adagrasib
mirati
['mrtx849', 'adagrasib']
icymi in , the first report of #adagrasib: the krasg12c inhibitor mrtx849 provides insight toward therapeutic susceptibility of kras-mutant cancers in mouse models and patients #asco22 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Tweets are my own. She/her